Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Antonio Miragliuolo"'
Publikováno v:
Journal of Ultrasound. 14:1-6
The interobserver variability of the sonographic assessment of Focal Bladder Wall Abnormalities (FBWA) between two physicians with different levels of experience was evaluated prospectively.In the same session the two operators examined independently
Autor:
Salvatore Del Prete, Sergio Bellini, Rosario Guarrasi, Vincenzo Faiola, Antonio Miragliuolo, Michele Lanna, Liliana Montella, Gregorio Cennamo, Alberto Abbruzzese, Raffaele Addeo, Bruno Vincenzi, Michele Caraglia
Publikováno v:
Journal of Clinical Oncology. 28:543-548
Purpose Approximately 30% to 40% patients with a superficial bladder cancer treated with Bacille Calmette-Guerin (BCG) or epirubicin do not respond; of the initial responders, 35% have a relapse within 5 years. We compare the therapeutic efficacy and
Autor:
Antonio Miragliuolo, Giampiero Francica, Sergio Bellini, Ferdinando Scarano, Fedele Antonio De Marino, Mauro Maniscalco
Publikováno v:
Journal of Ultrasound in Medicine. 27:887-894
Objective. The aim of this study was to prospectively assess the diagnostic capabilities of transabdominal sonography performed with newer sonography machines for showing focal bladder wall abnormalities (FBWAs) detected on cystoscopy. Methods. One h
Autor:
Roberto, Giulianelli, Stefano, Pecoraro, Giuseppe, Sepe, Rosario, Leonardi, Barbara Cristina, Gentile, Luca, Albanesi, Stefano, Brunori, Luca, Mavilla, Francesco, Pisanti, Renato, Giannella, Patrizia, Morello, Domenico, Tuzzolo, Mario, Coscione, Fabio, Galasso, Tammaro, D'Angelo, Paolo, Ferravante, Emilio, Morelli, Antonio, Miragliuolo
Publikováno v:
Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica. 84(2)
Chronic benign prostate diseases are very common and certainly feature significantly in urological practice.The treatment of chronic benign prostate diseases is a common problem in clinical practice: few studies have been conducted in routine clinica
Autor:
Liliana Montella, A. Schiano, Antonio Miragliuolo, Vincenzo Faiola, S. Del Prete, Sergio Bellini, Rosario Guarrasi, Luciano Tarantino, C. Pizza, R. Addeo
Publikováno v:
Journal of Clinical Oncology. 26:5075-5075
5075 Background: Approximately 30–40% of patients with a superficial bladder cancer treated with Bacille Calmette-Guerin (BCG) or epirubicin do not respond and other 35% of initial responders have a relapse within 5 years. We have compared the ther